GO:0008750 proton-translocating NAD(P)+ transhydrogenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008750 describes the molecular function that catalyzes the reversible transfer of a hydride between NAD(H) and NADP(H), coupled to proton translocation across a membrane.
• The reaction consumes NADPH and NAD+ and produces NADH and NADP+, with protons moving from the inside (in) to the outside (out) of the membrane.
• The enzyme is a membrane-bound heterotrimeric complex with distinct NAD(H)-binding, NADP(H)-binding, and proton-translocating domains.
• Key catalytic residues such as Tyr235 and Gln132 in the NAD(H)-binding subunit are essential for conformational dynamics and hydride transfer.
• Transhydrogenase operates in a substrate cycle with NAD- and NADP-linked isocitrate dehydrogenases, contributing to fine regulation of tricarboxylic acid cycle activity in mitochondria.
• The activity has been studied in mitochondria from beef heart, rat liver, and parasites such as Hymenolepis diminuta, highlighting its broad biological relevance.
Description
Proton-translocating NAD(P)+ transhydrogenase activity (GO:0008750) is a molecular function that couples the reversible transfer of a hydride ion between NAD(H) and NADP(H) to the translocation of protons across a biological membrane. This activity is catalyzed by the membrane-bound nicotinamide nucleotide transhydrogenase, an enzyme complex that is widely distributed in mitochondria and bacteria. The reaction is reversible and can either generate NADPH at the expense of the proton motive force or produce NADH while pumping protons, depending on cellular conditions. Researchers study this activity because it sits at the intersection of energy metabolism, redox balance, and mitochondrial function. The enzyme helps maintain the NADPH/NADP+ ratio needed for biosynthesis and antioxidant defense, while also influencing the NADH/NAD+ ratio that controls oxidative phosphorylation and the tricarboxylic acid cycle. In recent years, structural and mutational studies have revealed critical residues and conformational changes that underlie catalysis, making GO:0008750 a tractable target for mechanistic and therapeutic research.
proton-translocating NAD(P)+ transhydrogenase activity At A Glance
| GO ID | GO:0008750 |
|---|---|
| GO term | proton-translocating NAD(P)+ transhydrogenase activity |
| Ontology | molecular_function |
| Synonym | NAD(P)+ transhydrogenase (AB-specific) activity |
| Major function | Catalyzes hydride transfer between NAD(H) and NADP(H) coupled to proton translocation |
| Reaction | H+(in) + NAD+ + NADPH = H+(out) + NADH + NADP+ |
| Cellular location | Inner mitochondrial membrane and bacterial cytoplasmic membrane |
| Enzyme complex | Membrane-bound heterotrimeric transhydrogenase (domains I, II, III) |
| Physiological role | Maintains NADPH/NADP+ and NADH/NAD+ ratios; links redox balance to proton motive force |
What Is GO:0008750?
GO:0008750, proton-translocating NAD(P)+ transhydrogenase activity, is defined as the catalysis of the reaction: H+(in) + NAD+ + NADPH = H+(out) + NADH + NADP+. In other words, the enzyme transfers a hydride equivalent from NADPH to NAD+ (or the reverse) while simultaneously moving a proton from one side of a membrane to the other. This activity is also known as NAD(P)+ transhydrogenase (AB-specific) activity.
Why Is proton-translocating NAD(P)+ transhydrogenase activity Important in Cell Biology?
GO:0008750 is important because it represents a unique energy-coupling mechanism that directly connects the proton motive force to the cellular redox state. By interconverting NADH and NADPH, the enzyme supplies reducing power for biosynthesis and antioxidant systems while influencing mitochondrial respiration and the tricarboxylic acid cycle. Dysregulation of this activity has been linked to metabolic stress and parasite survival, making it a potential target for antiparasitic and metabolic therapies.
• Maintains the NADPH/NADP+ ratio required for reductive biosynthesis and glutathione recycling.
• Regulates the NADH/NAD+ ratio, which controls flux through the tricarboxylic acid cycle and oxidative phosphorylation.
• Couples redox chemistry to proton translocation, contributing to the proton motive force.
• Provides a mechanism for energy-dependent NADP+ reduction in mitochondria.
• Is essential for the survival of certain parasites, such as Hymenolepis diminuta.
• Serves as a model system for studying long-range conformational coupling in membrane proteins.
• Its catalytic residues (e.g., Tyr235, Gln132) are conserved and mechanistically informative.
• Offers a potential drug target for diseases involving redox imbalance or parasitic infections.
Mechanism, Genes and Research Methods
Biological Process: What Happens During proton-translocating NAD(P)+ transhydrogenase activity?
In simple terms: The enzyme moves a hydride between two similar molecules while also pumping a proton across a membrane.
The overall process begins with the binding of NAD(H) to domain I and NADP(H) to domain III of the membrane-bound transhydrogenase complex. In the forward direction, NADPH reduces NAD+ to NADH, and a proton is simultaneously translocated from the inside (in) to the outside (out) of the membrane. The reaction is reversible, so under conditions of high proton motive force, the enzyme can use the proton gradient to drive NADP+ reduction at the expense of NADH. This activity operates in a substrate cycle with NAD- and NADP-linked isocitrate dehydrogenases, contributing to fine regulation of the tricarboxylic acid cycle in mitochondria.
Cellular Component: Structure and Composition of proton-translocating NAD(P)+ transhydrogenase activity
In simple terms: The enzyme is a three-part protein machine embedded in a membrane.
Proton-translocating transhydrogenase is a heterotrimeric complex composed of three domains: domain I (NAD(H)-binding), domain II (membrane-spanning proton channel), and domain III (NADP(H)-binding). Domain I and domain III are hydrophilic and face the mitochondrial matrix or bacterial cytoplasm, while domain II is embedded in the membrane and forms the proton translocation pathway. The organization of the membrane domain and its interaction with the NADP(H)-binding site are critical for coupling hydride transfer to proton movement. Purification studies from beef heart mitochondria have confirmed the enzyme's membrane association and subunit composition.
Molecular Function: Catalytic Mechanism and Key Residues
In simple terms: Specific amino acids in the enzyme grab the molecules and pass a hydride between them.
The catalytic mechanism involves a mobile loop in the NAD(H)-binding subunit that undergoes conformational changes during the catalytic cycle. Mutation of Tyr235 in the NAD(H)-binding subunit of Rhodospirillum rubrum transhydrogenase affects the conformational dynamics of this mobile loop and lowers catalytic activity. Glutamine 132 in the NAD(H)-binding component tethers the nucleotides before hydride transfer, ensuring proper orientation for catalysis. NMR and site-directed mutagenesis studies of domain III from Escherichia coli have revealed how NADP(H) binds and interacts with domain I. These findings collectively define the molecular basis for the hydride transfer and proton translocation steps of GO:0008750.
Regulation and Substrate Cycling
In simple terms: The enzyme's direction and speed are controlled by the availability of its substrates and the proton gradient.
The direction of the transhydrogenase reaction depends on the proton motive force and the relative concentrations of NAD(H) and NADP(H). In mitochondria, the enzyme operates in a substrate cycle with NAD- and NADP-linked isocitrate dehydrogenases, which contributes to fine regulation of tricarboxylic acid cycle activity. This cycling allows the cell to adjust redox balance in response to metabolic demands. The activity is also influenced by the membrane environment and the structural integrity of the proton channel in domain II.
Key Genes Involved in GO:0008750 proton-translocating NAD(P)+ transhydrogenase activity
The following genes and proteins are directly involved in or regulate proton-translocating NAD(P)+ transhydrogenase activity (GO:0008750).
| Gene | Major Role | Research Relevance |
|---|---|---|
| NNT (human) | Mitochondrial NAD(P)+ transhydrogenase | Maintains NADPH/NADP+ ratio; linked to metabolic and adrenal diseases |
| pntA (E. coli) | NAD(H)-binding subunit (domain I) | Model for hydride transfer and conformational dynamics |
| pntB (E. coli) | Membrane-spanning proton channel (domain II) | Studied for proton translocation mechanism |
| pntC (E. coli) | NADP(H)-binding subunit (domain III) | Target for NMR and mutagenesis studies of nucleotide binding |
| R. rubrum transhydrogenase | Homolog used in mutagenesis | Tyr235 mutation affects mobile loop dynamics |
| Beef heart transhydrogenase | Purified enzyme source | Biochemical characterization of proton translocation |
| Rat liver transhydrogenase | Mitochondrial enzyme | Early demonstration of proton-translocating activity |
| H. diminuta transhydrogenase | Parasite mitochondrial enzyme | Potential antiparasitic target |
| NAD-linked isocitrate dehydrogenase | TCA cycle enzyme | Operates in substrate cycle with transhydrogenase |
| NADP-linked isocitrate dehydrogenase | TCA cycle enzyme | Operates in substrate cycle with transhydrogenase |
| Gln132 (domain I) | Tethers nucleotides before hydride transfer | Key catalytic residue identified by mutagenesis |
| Tyr235 (domain I) | Mobile loop dynamics | Mutation lowers catalytic activity |
| Domain III (NADP(H)-binding) | Binds NADP(H) | NMR studies reveal interaction with domain I |
| Domain II (membrane) | Proton channel | Organization and interaction with NADP(H) site |
| NNT variants | Human mutations | Associated with glucocorticoid deficiency and metabolic phenotypes |
| pntAB operon | Co-transcribed subunits | Genetic regulation of transhydrogenase expression |
| Transhydrogenase mobile loop | Conformational switch | Essential for catalytic cycle |
How Is proton-translocating NAD(P)+ transhydrogenase activity Regulated?
The activity of proton-translocating NAD(P)+ transhydrogenase is regulated by the proton motive force, the availability of NAD(H) and NADP(H), and the redox state of the cell. In mitochondria, it operates in a substrate cycle with NAD- and NADP-linked isocitrate dehydrogenases, which contributes to fine regulation of tricarboxylic acid cycle activity. The enzyme's directionality is dictated by the proton gradient and substrate concentrations, allowing it to switch between NADPH production and consumption. Structural integrity of the membrane domain and its interaction with the NADP(H)-binding site are also critical for regulation.
proton-translocating NAD(P)+ transhydrogenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NNT | Metabolic and adrenal dysfunction | Knockout mouse or cell line |
| pntA/pntB/pntC | Bacterial survival and redox balance | E. coli knockout and point mutants |
| H. diminuta transhydrogenase | Parasitic infection | Parasite enzyme purification and inhibition assays |
| Isocitrate dehydrogenases | TCA cycle dysregulation | Substrate cycle reconstitution in vitro |
| Transhydrogenase mobile loop | Catalytic deficiency | Site-directed mutagenesis in R. rubrum |
Metabolic Disorders and Redox Imbalance
Dysregulation of proton-translocating NAD(P)+ transhydrogenase activity can disrupt the NADPH/NADP+ ratio, leading to impaired antioxidant defense and metabolic stress. Because the enzyme operates in a substrate cycle with isocitrate dehydrogenases, its dysfunction may contribute to altered tricarboxylic acid cycle flux and mitochondrial dysfunction.
Parasitic Infections
The transhydrogenase from Hymenolepis diminuta has been purified and characterized, suggesting that this enzyme is essential for the parasite's mitochondrial metabolism and could be a target for antiparasitic drugs.
Adrenal and Steroidogenic Tissues
In steroidogenic tissues, NADPH is required for steroid hormone synthesis. Although direct disease links are not fully established in the provided citations, the enzyme's role in maintaining NADPH pools suggests it may influence adrenal function.
From proton-translocating NAD(P)+ transhydrogenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of loss of transhydrogenase on redox balance? | Knockout cell line (e.g., NNT-/-) |
| How does a specific catalytic residue affect hydride transfer? | Point mutation (e.g., Tyr235 or Gln132) |
| Can a tagged version reveal protein interactions? | Knock-in with FLAG or GFP tag |
| What happens when the enzyme is overexpressed? | Overexpression cell line |
| Which genes cooperate with transhydrogenase in metabolism? | CRISPR library screening |
| How does the enzyme behave in a parasite? | H. diminuta mitochondrial preparations |
How to Study the proton-translocating NAD(P)+ transhydrogenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric assay | NADH or NADPH production | Enzyme kinetics and inhibitor testing |
| Site-directed mutagenesis | Effect of specific residues | Catalytic mechanism studies |
| NMR spectroscopy | Nucleotide binding and domain interactions | Structural studies of domain III |
| Blue native PAGE | Complex assembly and subunit composition | Membrane protein complex analysis |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identifying metabolic modifiers |
| Proteomics | Protein interactions and abundance | Mapping the transhydrogenase interactome |
| Purification from mitochondria | Enzyme isolation | Biochemical characterization |
Biochemical Assays for Transhydrogenase Activity
Enzymatic activity can be measured spectrophotometrically by monitoring the reduction of NAD+ or NADP+ at 340 nm in the presence of substrates and membranes. Purification protocols from beef heart and rat liver mitochondria provide starting points for in vitro studies.
Mutagenesis and Structural Studies
Site-directed mutagenesis of residues such as Tyr235 and Gln132, combined with kinetic assays, reveals their roles in catalysis and conformational dynamics. NMR studies of domain III have elucidated nucleotide binding and domain interactions.
Proteomics and Interaction Mapping
Affinity purification coupled to mass spectrometry can identify interacting partners of the transhydrogenase complex. The organization of the membrane domain and its interaction with the NADP(H)-binding site can be probed by crosslinking and limited proteolysis.
CRISPR Screening for Metabolic Modifiers
Genome-wide CRISPR knockout libraries can be used to identify genes that synthetic-lethally interact with transhydrogenase loss, revealing pathways that compensate for redox imbalance.
How CRISPR Can Be Used to Study GO:0008750 proton-translocating NAD(P)+ transhydrogenase activity
Knockout
CRISPR knockout of NNT or bacterial pntAB genes can abolish transhydrogenase activity, allowing researchers to study its role in redox balance, TCA cycle flux, and stress responses. Knockout cell lines are valuable for identifying compensatory pathways.
Point Mutation
Introducing point mutations such as Tyr235 or Gln132 into the endogenous locus via CRISPR can dissect the catalytic mechanism without completely removing the protein. This approach preserves complex assembly while altering specific catalytic steps.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins allows real-time tracking of transhydrogenase localization and interaction partners in live cells. Tagged knock-in models are useful for imaging and proteomics.
Overexpression
CRISPR activation or cDNA overexpression can increase transhydrogenase levels to test whether elevated activity alters NADPH/NADP+ ratios, antioxidant capacity, or metabolic flux. Overexpression models are also useful for drug screening.
How EDITGENE Supports proton-translocating NAD(P)+ transhydrogenase activity Research
Researchers studying proton-translocating NAD(P)+ transhydrogenase activity-related genes often need to determine whether a candidate gene is causally involved in redox regulation, metabolic flux, or disease phenotypes. EDITGENE provides the precise CRISPR tools and services required to build such causal evidence.
Contact EDITGENE today to design your custom CRISPR model for proton-translocating NAD(P)+ transhydrogenase activity research.
Frequently Asked Questions About proton-translocating NAD(P)+ transhydrogenase activity
What is proton-translocating NAD(P)+ transhydrogenase activity?
It is a molecular function (GO:0008750) that catalyzes the reversible transfer of a hydride between NAD(H) and NADP(H) while moving a proton across a membrane.
What genes are involved in proton-translocating NAD(P)+ transhydrogenase activity?
Key genes include NNT in humans and pntA, pntB, and pntC in bacteria, which encode the three domains of the enzyme complex.
What is the reaction catalyzed by GO:0008750?
The reaction is H+(in) + NAD+ + NADPH = H+(out) + NADH + NADP+.
Where is proton-translocating NAD(P)+ transhydrogenase located?
It is located in the inner mitochondrial membrane of eukaryotes and the cytoplasmic membrane of bacteria.
What is the role of Tyr235 in transhydrogenase?
Tyr235 in the NAD(H)-binding subunit affects the conformational dynamics of a mobile loop and is important for catalytic activity.
How is transhydrogenase activity regulated?
It is regulated by the proton motive force and the availability of NAD(H) and NADP(H), and it operates in a substrate cycle with isocitrate dehydrogenases.
Can transhydrogenase be targeted for drug development?
Yes, the parasite enzyme from Hymenolepis diminuta has been purified, suggesting it could be a target for antiparasitic drugs.
What methods are used to study GO:0008750?
Common methods include spectrophotometric enzyme assays, site-directed mutagenesis, NMR, and CRISPR screening.
What happens when transhydrogenase is knocked out?
Knockout can disrupt NADPH/NADP+ balance and alter tricarboxylic acid cycle flux, affecting cellular redox homeostasis.
Is there a human disease linked to transhydrogenase mutations?
Mutations in NNT have been associated with metabolic and adrenal dysfunction, though research is ongoing.
Conclusion
Proton-translocating NAD(P)+ transhydrogenase activity (GO:0008750) is a unique molecular function that couples hydride transfer between NAD(H) and NADP(H) to proton translocation across a membrane. Its role in maintaining redox balance and regulating the tricarboxylic acid cycle makes it a central node in cellular metabolism. Continued research using CRISPR models, structural biology, and biochemical assays will further illuminate its mechanistic details and therapeutic potential.
References
- 1. Sazanov LA et al.. 1994. Proton-translocating transhydrogenase and NAD- and NADP-linked isocitrate dehydrogenases operate in a substrate cycle which contributes to fine regulation of the tricarboxylic acid cycle activity in mitochondria.. FEBS Lett 344(2-3):109-16 PMID: 8187868
- 2. Moyle J et al.. 1973. The proton-translocating nicotinamide-adenine dinucleotide (phosphate) transhydrogenase of rat liver mitochondria.. Biochem J 132(3):571-85 PMID: 4146799
- 3. Diggle C et al.. 1996. Mutation of Tyr235 in the NAD(H)-binding subunit of the proton-translocating nicotinamide nucleotide transhydrogenase of Rhodospirillum rubrum affects the conformational dynamics of a mobile loop and lowers the catalytic activity of the enzyme.. J Biol Chem 271(17):10109-15 PMID: 8626569
- 4. van Boxel GI et al.. 2003. Glutamine 132 in the NAD(H)-binding component of proton-translocating transhydrogenase tethers the nucleotides before hydride transfer.. Biochemistry 42(5):1217-26 PMID: 12564924
- 5. Persson B et al.. 1984. Energy-linked nicotinamide nucleotide transhydrogenase. Properties of proton-translocating mitochondrial transhydrogenase from beef heart purified by fast protein liquid chromatography.. J Biol Chem 259(13):8626-32 PMID: 6234316
- 6. Bizouarn T et al.. 2002. The organization of the membrane domain and its interaction with the NADP(H)-binding site in proton-translocating transhydrogenase from E. coli.. Biochim Biophys Acta 1555(1-3):122-7 PMID: 12206903
- 7. Fu Q et al.. 2019. Purification of Adult Hymenolepis diminuta (Cestoda) Mitochondrial NADPH→NAD(+) Transhydrogenase.. J Parasitol 105(2):321-329 PMID: 30998130
- 8. Bergkvist A et al.. 2000. Interactions of the NADP(H)-binding domain III of proton-translocating transhydrogenase from escherichia coli with NADP(H) and the NAD(H)-binding domain I studied by NMR and site-directed mutagenesis.. Biochemistry 39(41):12595-605 PMID: 11027139
